

Diagnostic difficulties of paraneoplastic neurological syndrome (clinical case)
Heading: Тhematic supplement Article type: Case report
Authors: Goncharova Z.A., Milovanova O.V., Manasyan N.Yu.
Organization:
The article presents a rare case of a combination of two paraneoplastic syndromes at the stage of preclinical detection of neoplasm. This example is a vivid illustration of the complexity of the diagnosis of paraneoplastic syndromes at an early stage, associated with the appearance of neurological symptoms prior the detection of the primary tumor.
Bibliography:
1. Binks S, Uy C, Honnorat J, Irani SR. Paraneoplastic neurological syndromes: a practical approach to diagnosis and management. Pract Neurol 2022; 22 (1): 19-31.
2. Shnaider NA, Ezhikova VV, Dykhno YuA, et al. Diagnosis problems of paraneoplastic cerebellar degeneration. Neurology, Neuropsychiatry, Psychosomatics2014; (1): 35-43.
3. Xuan S, Jiping Т, Hui S, et al. Anti-SOX1 antibodies in paraneoplastic neurological syndrome. J Clin Neurol 2020; 16 (4): 530-46.
4. Jayarangaiah A, Theetha KP Lambert Eaton myasthenic syndrome. Treasure Island (FL): StatPearls Publishing, 2020. URL: https://www.ncbi.nlm.nih.gov/books/NBK507891 (15 Jul 2021).
5. Graus F, Vogrig A, Muniz-Castrillo S, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 2021; 8 (4): 1014.
6. Jiraporn J, Pritikanta P, Smathorn Th, et al. Paraneoplastic neurological syndrome: an evolving story. Neurooncol Pract 2021; 8 (4): 362-74.
7. Bekircan-Kurt CE, Derle Ciftci E, Kurne AT, Anlar B. Voltage gated calcium channel antibody-related neurological diseases. World J Clin Cases 2015; 3 (3): 293-300.
8. Ivanovski T, Miralles F. Lambert-Eaton myasthenic syndrome: early diagnosis is key. Degener Neurol Neuromuscul Dis2019; (9): 27-37.
Attachment | Size |
---|---|
2022_01-1_107-111.pdf | 318.23 KB |